You are on page 1of 6

Buffalo Filter Acquisition Overview

December 13, 2018


Forward-Looking Information

This presentation contains forward-looking statements based on certain assumptions and contingencies that
involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's performance on
a going-forward basis. The forward-looking statements in this presentation involve risks and uncertainties
which could cause actual results, performance or trends, to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. In addition to general industry and economic
conditions, factors that could cause actual results to differ materially from those discussed in the forward-
looking statements in this presentation include, but are not limited to, the risk factors discussed in the
Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2017, and listed under the
heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q.

Management has disclosed adjusted financial measurements in this presentation that present financial
information that is not in accordance with generally accepted accounting principles (GAAP). These adjusted
financial measures are helpful to management in comparing the recurring aspects of the business performance
without the effect of unusual, non-recurring or special revenues or costs. These measurements are not a
substitute for GAAP measurements. Investors should consider adjusted measures in addition to, and not as a
substitute for, or superior to, financial performance measures prepared in accordance with GAAP.

2
What is Surgical Smoke?

Surgical smoke poses significant health risks to surgical personnel

Overview Scope of the Problem


• Surgical smoke is a dangerous by-product generated from the use • Over 500K healthcare workers are exposed
of lasers, electro-surgical pencils, ultrasonic devices, and other to surgical smoke annually in the U.S.
surgical energy-based devices. • Smoke is created in 95% of all procedures.
• As these instruments cauterize vessels and destroy (vaporize) • Causes respiratory and eye irritations, as
tissue, fluid, and blood, a gaseous material known as surgical well as nausea in healthcare professionals
smoke is created.
• Proven to contain toxic gases, live cellular material (including blood
fragments), and viruses, surgical smoke causes significant risks to
both surgical personnel and patients.

Dangers of Surgical Smoke


Hazardous Components

Chemical Biological Chemical


40 different carcinogenic Known to carry intact Ultra-fine particulate
chemicals similar to human and viral DNA similar to coal dust
cigarette smoke Surgical Smoke = 27-30
Cigarettes / Day*

*Hill DS, O’Neill JK, Powell RJ, Oliver DW. Surgical smoke—a health hazard in the operating theatre: a study to quantify exposure and a
3
survey of the use of smoke extractor systems in UK plastic surgery units. J Plast Reconstr Aesthet Surg. 2012; 65(7):911-916.
Surgical Smoke Removal Market Opportunity

• There are approximately ~300M surgical procedures performed globally on an annual basis; 95% of all surgical procedures utilize energy, which produces
hazardous surgical smoke.
• Research and workplace studies conducted over long periods of time confirm that surgical smoke contains hazardous substances including respiratory irritants
and carcinogens that have been linked to asthma, and infectious agents such as human papilloma virus (HPV).
• Regulation/legislation will mandate adoption – leading to market sector growth.
• Market has seen leading regulation in the following geographies:

• Canadian smoke • Denmark: • Australia, New • Rhode Island • California has pending • Colorado and
regulation initiated in 2010 Working Zealand and the UK legislation (law to regulation through Massachusetts have
2009 and was revised Environment Act - have also enacted make OR’s smoke OSHA pending legislation
in 2013 by the mandates the regulations that free) becomes • In November
Canadian Standards removal of carry the force of law effective Jan. 2019 (Cal/OSHA) convened
Association (CSA) surgical smoke to protect surgical an advisory meeting to
• Smoke removal is now • Many Nordic workers from consider development of
the standard of care countries have surgical smoke a rulemaking proposal to
followed suit protect employees from
without regulation surgical smoke

“The Association of Operating Room Nurses (AORN), in its “2017 AORN Guideline for Surgical Smoke Safety”, recommended the following:”
• “The health care organization should provide a surgical smoke free environment.”
• “The perioperative team should evacuate all surgical smoke.”
• “The collective evidence, standards, and guidelines from The National Institute for Occupational Safety and Health (NIOSH), the Healthcare Infection Control Practices Advisory Committee,
and professional organizations indicate that evacuating surgical smoke protects patients and health care workers from the hazards of surgical smoke.”

4
Buffalo Filter Product Portfolio

Buffalo Filter is the #1 player in the surgical smoke evacuation market


• The current market is ~$100 million
• The market CAGR is 20%
Four main product categories: 1) Surgical Smoke Evacuation Pencils, 2) Surgical Smoke Evacuators
and Filters, 3) Laparoscopic Solutions, and 4) Accessories

CORE COMPETENCIES
ü Filtration Technologies
ü Full Equipment Design and Execution
ü Design for Manufacturability
ü PC Board Development & Validation
Evacuation Pencils Smoke Evacuators
ü 85% of Revenue from Consumables
ü Compact pens provide smoke ü Advanced evacuators provide turbo
ü Flow Dynamics and Management evacuation at the surgical site suction power to capture smoke

ü Regulatory Submissions
ü Patent Filings
ü Advanced Research, Design and 3D Printing Capabilities

5
Financial Summary ($ in millions)
Purchase Price $ 365
Tax Amortization Benefit 60
Tax Adjusted Purchase Price $ 305
Multiple paid on
2018 2019 Est* Next 12 Months
Revenue (net of sales to CONMED) $ 41.0 $47 to $50 6.1 to 6.5
Gross Margins in the mid-50% range Improving after the first year
EBITDA (25%) $ 10.3 $3 - $5 million in $15 to $17 17.9 to 20.3
1st year synergies
(increasing thereafter)

Adjusted Cash EPS Accretion Neutral 10 to 15 cents in 2020


*These estimates for 2019 represent a full year (12 months) of impact. The acquisition is estimated to close in the first quarter of 2019, so the financial impact on
Conmed’s 2019 numbers will be less than the numbers presented here.

Impact on organic growth profile:


• Adds approx. 50 bps to revenue growth initially and increases in future years
• Adds approx. 100 bps to EBITDA margin profile in 1st year, and an additional 100 bps by year 3

You might also like